Search

Record Type Journal Article Author/Creator Staddon, Arthur P.

1. A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Issue 16 (2nd May 2014)

Authors:
Pappo, Alberto S.; Vassal, Gilles; Crowley, John J.; Bolejack, Vanessa; Hogendoorn, Pancras C. W.; Chugh, Rashmi; Ladanyi, Marc; Grippo, Joseph F.; Dall, Georgina; Staddon, Arthur P.; Chawla, Sant P.; Maki, Robert G.; Araujo, Dejka M.; Geoerger, Birgit; Ganjoo, Kristen; Marina, Neyssa; Blay, Jean...
Journal:
Cancer
Issue:
Volume 120:Issue 16(2014)
Page Start:
2448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2 trial of R1507, a monoclonal antibody to the insulin‐like growth factor‐1 receptor (IGF‐1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Issue 16 (2nd May 2014)

Authors:
Pappo, Alberto S.; Vassal, Gilles; Crowley, John J.; Bolejack, Vanessa; Hogendoorn, Pancras C. W.; Chugh, Rashmi; Ladanyi, Marc; Grippo, Joseph F.; Dall, Georgina; Staddon, Arthur P.; Chawla, Sant P.; Maki, Robert G.; Araujo, Dejka M.; Geoerger, Birgit; Ganjoo, Kristen; Marina, Neyssa; Blay, Jean...
Journal:
Cancer
Issue:
Volume 120:Issue 16(2014)
Page Start:
2448
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Issue 1 (3rd October 2016)

Authors:
Schuetze, Scott M.; Bolejack, Vanessa; Choy, Edwin; Ganjoo, Kristen N.; Staddon, Arthur P.; Chow, Warren A.; Tawbi, Hussein A.; Samuels, Brian L.; Patel, Shreyaskumar R.; von Mehren, Margaret; D'Amato, Gina; Leu, Kirsten M.; Loeb, David M.; Forscher, Charles A.; Milhem, Mohammed M.; Rushing, Dani...
Journal:
Cancer
Issue:
Volume 123:Issue 1(2017)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate‐grade or high‐grade liposarcoma. Issue 23 (18th August 2017)

Authors:
Samuels, Brian L.; Chawla, Sant P.; Somaiah, Neeta; Staddon, Arthur P.; Skubitz, Keith M.; Milhem, Mohammed M.; Kaiser, Pamela E.; Portnoy, David C.; Priebat, Dennis A.; Walker, Mark S.; Stepanski, Edward J.
Journal:
Cancer
Issue:
Volume 123:Issue 23(2017)
Page Start:
4640
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma. Issue 6 (28th December 2015)

Authors:
Schuetze, Scott M.; Wathen, J. Kyle; Lucas, David R.; Choy, Edwin; Samuels, Brian L.; Staddon, Arthur P.; Ganjoo, Kristen N.; von Mehren, Margaret; Chow, Warren A.; Loeb, David M.; Tawbi, Hussein A.; Rushing, Daniel A.; Patel, Shreyaskumar R.; Thomas, Dafydd G.; Chugh, Rashmi; Reinke, Denise K.; ...
Journal:
Cancer
Issue:
Volume 122:Issue 6(2016)
Page Start:
868
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗